title: Vemurafenib-induced panniculitis.
authors.forename: Axel Patrice
authors.initials: AP
authors.lastname: Villani
authors.forename: Danièla
authors.initials: D
authors.lastname: Zaharia
authors.forename: Stéphane
authors.initials: S
authors.lastname: Dalle
authors.forename: Laurianne
authors.initials: L
authors.lastname: Depaepe
authors.forename: Brigitte
authors.initials: B
authors.lastname: Balme
authors.forename: Luc
authors.initials: L
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D015434:Panniculitis / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib